Clinical Radiology
Volume 63, Issue 2 , Pages 153-159 , February 2008

Dynamic contrast-enhanced MRI of benign prostatic hyperplasia and prostatic carcinoma: correlation with angiogenesis

  • J. Ren

      Affiliations

    • Department of Radiology, Xijing Hospital, Fourth Military Medical University, Xi'an, People's Republic of China
    • ,
  • Y. Huan

      Affiliations

    • Department of Radiology, Xijing Hospital, Fourth Military Medical University, Xi'an, People's Republic of China
    • Corresponding Author InformationGuarantor and correspondent: Y. Huan, Department of Radiology, Xijing Hospital, Fourth Military Medical University, Chang Le Western Road No. 15, Xi'an 710032, People's Republic of China. Tel./fax: +86 29 84775421.
    • ,
  • H. Wang

      Affiliations

    • Department of Urology, Xijing Hospital, Fourth Military Medical University, Xi'an, People's Republic of China
    • ,
  • Y.-J. Chang

      Affiliations

    • Department of Radiology, Xijing Hospital, Fourth Military Medical University, Xi'an, People's Republic of China
    • ,
  • H.-T. Zhao

      Affiliations

    • Department of Radiology, Xijing Hospital, Fourth Military Medical University, Xi'an, People's Republic of China
    • ,
  • Y.-L. Ge

      Affiliations

    • Department of Radiology, Xijing Hospital, Fourth Military Medical University, Xi'an, People's Republic of China
    • ,
  • Y. Liu

      Affiliations

    • Department of Radiology, Xijing Hospital, Fourth Military Medical University, Xi'an, People's Republic of China
    • ,
  • Y. Yang

      Affiliations

    • Department of Radiology, Xijing Hospital, Fourth Military Medical University, Xi'an, People's Republic of China

Received 16 November 2006 ,Revised 19 July 2007 ,Accepted 25 July 2007.

References 

  1. Greenlee RT, Murray T, Bolden S, et al. Cancer statistics. CA Cancer J Clin. 2000;50:7–33
  2. Robert A, Andrew C, Richard W, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. CA Cancer J Clin. 2001;51:38–75
  3. Perrotti M, Han KR, Epstein RE, et al. Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostastic biopsy: a pilot study. J Urol. 1999;162:1314–1317
  4. Bigler SA, Deering RE, Brawer MK. Comparison of microscopic vascularity in benign and malignant prostate tissue. Hum Pathol. 1993;24:220–226
  5. Hawighorst H, Knapstein PG, Knopp MV, et al. Cervical carcinoma: standard and pharmacokinetic analysis of time–intensity curve for assessment of tumours angiogenesis and patient survival. MAGMA. 1999;8:55–62
  6. Checkley D, Tessier JJ, Kendrew J, et al. Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours. Br J Cancer. 2003;89:1889–1895
  7. Preziosi P, Orlacchio A, Giambattista GD, et al. Enhancement patterns of prostate cancer in dynamic MRI. Eur Radiol. 2003;13:925–930
  8. Rouviere O, Raudrant A, Ecochard R, et al. Characterization of time-enhancement curives of benign and malignant prostate tissue at dynamic MR imaging. Eur Radiol. 2003;13:931–942
  9. Kiessling F, Lichy M, Grobholz R, et al. Simple models improve the discrimination of prostate cancers from the peripheral gland by T1-weighted dynamic MRI. Eur Radiol. 2004;14:1793–1801
  10. Weidner N, Semple JP, Welch WR, et al. Tumour angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med. 1991;324:1–8
  11. Hara N, Okuizumi M, Koike H, et al. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer. Prostate. 2005;62:140–147
  12. Heverhagen JT, von H, Baudendistel KT, et al. Benign prostate hyperplasia: evaluation of treatment response with DCE MRI. MAGMA. 2004;17:5–11
  13. Bammer R. Basic principles of diffusion-weighted imaging. Eur J Radiol. 2003;45:169–184
  14. Gibbs P, Tozer DJ, Liney GP, et al. Comparison of quantitative T2 mapping and diffusion-weighted imaging in the normal and pathologic prostate. Magn Reson Med. 2001;46:1054–1058
  15. Folkman J, Watson K, Ingber D, et al. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature. 1989;339:58–61
  16. Folkman J. Clinical applications of research on angiogenesis. N Engl J Med. 1995;333:1757–1763
  17. Fox SB. Tumour angiogenesis and prognosis. Histopathology. 1997;30:294–301
  18. Angeletti CA, Lucchi M, Fontanini G, et al. Prognostic significance of tumoural angiogenesis in completely resected late stage lung carcinoma (stage IIIA-N2). Cancer. 1996;78:409–415
  19. Tuncbilek N, Karakas HM, Okten OO. Dynamic magnetic resonance imaging in determining histopathological prognostic factors of invasive breast cancers. Eur J Radiol. 2005;53:199–205
  20. Egmont-Petersen M, Hogendoorn PC, Geest RJ, et al. Detection of areas with viable remnant tumour in postchemotherapy patients with Ewing's sarcoma by dynamic contrast-enhanced MRI using pharmacokinetic modeling. Magn Reson Imaging. 2000;18:525–535
  21. Padhani AR, Gapinski CJ, Macvicar DA, et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol. 2000;55:99–109
  22. Hawighorst H, Knapstein PG, Knopp MV, et al. Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumour angiogenesis and patient survival. Cancer Res. 1998;58:3598–3602
  23. Juergen FS, Joachim V, Fritz S, et al. Solitary pulmonary nodules: dynamic contrast-enhanced MR imaging—perfusion differences in malignant and benign lesions. Radiology. 2004;232:544–553
  24. Deering RE, Bigler SA, Brawer MK, et al. Microvascularity in benign prostatic hyperplasia. Prostate. 1995;26:111–115
  25. Krupski T, Harding MA, Herce ME, et al. The role of vascular endothelial growth factor in the tissue specific in vivo growth of prostate cancer cells. Growth Factors. 2001;18:287–302
  26. Cetinkaya M, Gunce S, Ulusoy E, et al. Relationship between prostate specific antigen density, microvessel density and prostatic volume in benign prostatic hyperpiasia and advanced prostatic carcinoma. Int Urol Nephrol. 1998;30:581–585
  27. Rehman S, Jayson GC. Molecular imaging of antiangiogenic agents. Oncologist. 2005;10:92–103
  28. Karam JA, Mason RP, Koeneman KS, et al. Molecular imaging in prostate cancer. J Cell Biochem. 2003;90:473–483
  29. Bagnall S, Klotz L. Conservative versus radical therapy of prostate cancer: how have recent advances in molecular markers and imaging enhanced our ability to prognosticate risk?. Oncol. 2003;30:587–595

PII: S0009-9260(07)00341-8

doi: 10.1016/j.crad.2007.07.023

Clinical Radiology
Volume 63, Issue 2 , Pages 153-159 , February 2008

Article Tools

* Image Usage & Resolution